FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3189551730> ?p ?o ?g. }

• W3189551730 startingPage "4233" @default.
• W3189551730 abstract "Abstract Similar to many non-hematologic malignancies, TP53 mutations also arise in myeloid neoplasms (MN). Loss of function or hypomorphic TP53 mutations confers risks of both malignancy onset and accelerated progression to more aggressive disease. To exert full oncogenic function, somatic or inherited (Li-Fraumeni syndrome) heterozygous TP53 mutations require inactivating second allele hits, e.g ., uniparental disomy (UPD) or deletions. Recently, mutations in PPM1D, which encodes P53-induced protein phosphatase-1 (WIP-1), were reported in non-hematologic neoplasms and healthy controls with clonal hematopoiesis. The mutations are mostly inactivating hits due to truncation via nonsense or frame shift mutations. PPM1D is located in 17q23.2 and encodes for a PP2c family serine/threonine phosphatase that has a direct inhibitory effect on key members of the check point pathway, including TP53, CHK1 and CHK2. As most of the mutations are in the C-terminal domain, upon truncation, the N-terminal catalytic phosphatase domain remains and is overexpressed due to a compensatory mechanism. The increased phosphatase activity prevents TP53 activation by kinases and thus, overall, inhibits its function. Truncating PPM1D mutations are thus expected to have effects similar to those of TP53 losses of function. Our study goal was to elucidate how PPM1D mutations along with TP53 lesionsshape the phenotype of patients with MNs. In 2,709 MNs, 6% (163/2,709) of cases harbored TP53 and 1.6% (43/2,709) PPM1D mutations. UPD and deletions of TP53 locus were present in 12%, while biallelic hits in 10% of mutant cases. All PPM1D mutations were heterozygous. TP53 and PPM1D mutations were mutually exclusive, but were common in tMDS/AML (therapy related myelodysplastic syndrome/acute myeloid leukemia) found in 13.5% and 4.4% of patients, respectively; Of note is that TP53 mutations were mostly enriched in patients with history of chemotherapy rather than radiation (see our abstract on tMN: Kuzmanovich et al). No PPM1D mutations were found in MDS or AML, where TP53 was present in 6% of patients. Using publicly available GEO datasets GSE19429 (183 MDS cases) and GSE13159 (253 MDS and 351 AML cases), we sought correlations between high PPM1D mRNA and PPM1D truncations. Using the mean + standard deviation as the cut-off for calling an mRNA level overexpressed, overexpression was found in 24% of MDS and 21% of AML. In a subset analysis of AML, the frequency of PPM1D mutations was significantly higher in AML with complex vs. normal karyotypes (38% vs. 17%; Odds ratio 3.5 (95%CI: 1.7-7.0; P=.0005). TP53 and PPM1D mutations are functionally related but mutually exclusive and arise across a similar spectrum of MNs, specifically tMN. PPM1D mutations and high PPM1Dexpression are involved in MN pathogenesis. TP53 hits can be ancestral or secondary in spontaneous MDS/AML. PPM1D mutations are somatic, exclusively present in tMN, and thus TP53 and PPM1D mutations are enriched in tMDS, likely because chemotherapy exerts systemic selective pressure for apoptosis resistant cells. It is possible that preexisting tiny clones with biallelic T P53 mutations are being selected for chemotherapy. Current technologies are not able to distinguish small homozygous clones from large heterozygous clones. Disclosures Sekeres: Celgene: Membership on an entity's Board of Directors or advisory committees." @default.
• W3189551730 created "2021-08-16" @default.
• W3189551730 creator A5015705148 @default.
• W3189551730 creator A5016810759 @default.
• W3189551730 creator A5016847107 @default.
• W3189551730 creator A5019215418 @default.
• W3189551730 creator A5020361326 @default.
• W3189551730 creator A5022299669 @default.
• W3189551730 creator A5023037620 @default.
• W3189551730 creator A5055740968 @default.
• W3189551730 creator A5059910743 @default.
• W3189551730 creator A5063314967 @default.
• W3189551730 creator A5072967096 @default.
• W3189551730 creator A5085974329 @default.
• W3189551730 creator A5086233229 @default.
• W3189551730 date "2017-12-08" @default.
• W3189551730 modified "2023-09-28" @default.
• W3189551730 title "PPM1D Mutations and up Modulation Phenocopy TP53 Lesions in Myeloid Neoplasms" @default.
• W3189551730 doi "https://doi.org/10.1182/blood.v130.suppl_1.4233.4233" @default.
• W3189551730 hasPublicationYear "2017" @default.
• W3189551730 type Work @default.
• W3189551730 sameAs 3189551730 @default.
• W3189551730 citedByCount "0" @default.
• W3189551730 crossrefType "journal-article" @default.
• W3189551730 hasAuthorship W3189551730A5015705148 @default.
• W3189551730 hasAuthorship W3189551730A5016810759 @default.
• W3189551730 hasAuthorship W3189551730A5016847107 @default.
• W3189551730 hasAuthorship W3189551730A5019215418 @default.
• W3189551730 hasAuthorship W3189551730A5020361326 @default.
• W3189551730 hasAuthorship W3189551730A5022299669 @default.
• W3189551730 hasAuthorship W3189551730A5023037620 @default.
• W3189551730 hasAuthorship W3189551730A5055740968 @default.
• W3189551730 hasAuthorship W3189551730A5059910743 @default.
• W3189551730 hasAuthorship W3189551730A5063314967 @default.
• W3189551730 hasAuthorship W3189551730A5072967096 @default.
• W3189551730 hasAuthorship W3189551730A5085974329 @default.
• W3189551730 hasAuthorship W3189551730A5086233229 @default.
• W3189551730 hasConcept C104317684 @default.
• W3189551730 hasConcept C105951970 @default.
• W3189551730 hasConcept C11960822 @default.
• W3189551730 hasConcept C12387725 @default.
• W3189551730 hasConcept C127716648 @default.
• W3189551730 hasConcept C143065580 @default.
• W3189551730 hasConcept C176944494 @default.
• W3189551730 hasConcept C178666793 @default.
• W3189551730 hasConcept C389152 @default.
• W3189551730 hasConcept C501734568 @default.
• W3189551730 hasConcept C502942594 @default.
• W3189551730 hasConcept C54355233 @default.
• W3189551730 hasConcept C75563809 @default.
• W3189551730 hasConcept C86803240 @default.
• W3189551730 hasConcept C96777560 @default.
• W3189551730 hasConceptScore W3189551730C104317684 @default.
• W3189551730 hasConceptScore W3189551730C105951970 @default.
• W3189551730 hasConceptScore W3189551730C11960822 @default.
• W3189551730 hasConceptScore W3189551730C12387725 @default.
• W3189551730 hasConceptScore W3189551730C127716648 @default.
• W3189551730 hasConceptScore W3189551730C143065580 @default.
• W3189551730 hasConceptScore W3189551730C176944494 @default.
• W3189551730 hasConceptScore W3189551730C178666793 @default.
• W3189551730 hasConceptScore W3189551730C389152 @default.
• W3189551730 hasConceptScore W3189551730C501734568 @default.
• W3189551730 hasConceptScore W3189551730C502942594 @default.
• W3189551730 hasConceptScore W3189551730C54355233 @default.
• W3189551730 hasConceptScore W3189551730C75563809 @default.
• W3189551730 hasConceptScore W3189551730C86803240 @default.
• W3189551730 hasConceptScore W3189551730C96777560 @default.
• W3189551730 hasLocation W31895517301 @default.
• W3189551730 hasOpenAccess W3189551730 @default.
• W3189551730 hasPrimaryLocation W31895517301 @default.
• W3189551730 hasRelatedWork W112180865 @default.
• W3189551730 hasRelatedWork W2068140004 @default.
• W3189551730 hasRelatedWork W2069451615 @default.
• W3189551730 hasRelatedWork W2275283368 @default.
• W3189551730 hasRelatedWork W2538398683 @default.
• W3189551730 hasRelatedWork W2538799886 @default.
• W3189551730 hasRelatedWork W2542208644 @default.
• W3189551730 hasRelatedWork W2549442052 @default.
• W3189551730 hasRelatedWork W2552704622 @default.
• W3189551730 hasRelatedWork W2573014154 @default.
• W3189551730 hasRelatedWork W2574793802 @default.
• W3189551730 hasRelatedWork W2579125809 @default.
• W3189551730 hasRelatedWork W2579465600 @default.
• W3189551730 hasRelatedWork W2586657200 @default.
• W3189551730 hasRelatedWork W2589130651 @default.
• W3189551730 hasRelatedWork W2591891714 @default.
• W3189551730 hasRelatedWork W2979464342 @default.
• W3189551730 hasRelatedWork W2980234493 @default.
• W3189551730 hasRelatedWork W2980686553 @default.
• W3189551730 hasRelatedWork W3178364561 @default.
• W3189551730 hasVolume "130" @default.
• W3189551730 isParatext "false" @default.
• W3189551730 isRetracted "false" @default.
• W3189551730 magId "3189551730" @default.
• W3189551730 workType "article" @default.